Cargando…

Stroma secreted IL6 selects for “stem-like” population and alters pancreatic tumor microenvironment by reprogramming metabolic pathways

Pancreatic adenocarcinoma is a devastating disease with an abysmal survival rate of 9%. A robust fibro-inflammatory and desmoplastic stroma, characteristic of pancreatic cancer, contribute to the challenges in developing viable therapeutic strategies in this disease. Apart from constricting blood ve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kesh, Kousik, Garrido, Vanessa T., Dosch, Austin, Durden, Brittany, Gupta, Vineet K., Sharma, Nikita S., Lyle, Michael, Nagathihalli, Nagaraj, Merchant, Nipun, Saluja, Ashok, Banerjee, Sulagna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658205/ https://www.ncbi.nlm.nih.gov/pubmed/33177492 http://dx.doi.org/10.1038/s41419-020-03168-4

Ejemplares similares

Long non-coding RNA GAS5 acts as proliferation “brakes” in CD133+ cells responsible for tumor recurrence
por: Sharma, Nikita S., et al.
Publicado: (2019)

Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC
por: Kesh, Kousik, et al.
Publicado: (2022)

Therapy Resistance, Cancer Stem Cells and ECM in Cancer: The Matrix Reloaded
por: Kesh, Kousik, et al.
Publicado: (2020)

ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining “stemness”
por: Dauer, Patricia, et al.
Publicado: (2019)

Remodeling of Stromal Immune Microenvironment by Urolithin A Improves Survival with Immune Checkpoint Blockade in Pancreatic Cancer
por: Mehra, Siddharth, et al.
Publicado: (2023)

New mechanistic insights into modifiable risk factors that promote pancreatic cancer
por: Srinivasan, Supriya, et al.
Publicado: (2019)

Emerging targets in pancreatic cancer: epithelial–mesenchymal transition and cancer stem cells
por: Castellanos, Jason A, et al.
Publicado: (2013)

O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stability
por: Sharma, Nikita S, et al.
Publicado: (2019)

Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells
por: Dosch, Austin R., et al.
Publicado: (2019)

Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma
por: Kesh, Kousik, et al.
Publicado: (2020)

Learning From Gender Disparity: Role of Estrogen Receptor Activation in Coping With Pancreatic Cancer
por: Gupta, Vineet K., et al.
Publicado: (2020)

Optical Imaging of Drug-Induced Metabolism Changes in Murine and Human Pancreatic Cancer Organoids Reveals Heterogeneous Drug Response
por: Walsh, Alex J., et al.
Publicado: (2016)

Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells
por: Nagathihalli, Nagaraj S., et al.
Publicado: (2016)

GRP78‐mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells
por: Dauer, Patricia, et al.
Publicado: (2018)

A Theranostic Approach to Target Gastrin in Pancreatic Cancer
por: Banerjee, Sulagna, et al.
Publicado: (2018)

Deciphering high risk molecular alterations in gastrointestinal malignancy utilizing an extreme outlier strategy
por: Dosch, Austin R., et al.
Publicado: (2020)

Adiponectin receptor agonists inhibit leptin induced pSTAT3 and in vivo pancreatic tumor growth
por: Messaggio, Fanuel, et al.
Publicado: (2017)

Microenvironment mediated alterations to metabolic pathways confer increased chemo-resistance in CD133(+) tumor initiating cells
por: Nomura, Alice, et al.
Publicado: (2016)

Inhibition of hypoxic response decreases stemness and reduces tumorigenic signaling due to impaired assembly of HIF1 transcription complex in pancreatic cancer
por: McGinn, Olivia, et al.
Publicado: (2017)

Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment
por: Mishra, Deepshikha, et al.
Publicado: (2019)

Inhibition of Sp1 prevents ER homeostasis and causes cell death by lysosomal membrane permeabilization in pancreatic cancer
por: Dauer, Patricia, et al.
Publicado: (2017)

Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and Reprogramming Immunosuppressive Microenvironment
por: Zhang, Yue, et al.
Publicado: (2023)

Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment
por: Menon, Hari, et al.
Publicado: (2019)

Hypoxia-mediated apoptosis in oral carcinoma cells occurs via two independent pathways
por: Nagaraj, Nagathihalli S, et al.
Publicado: (2004)

Targeting PI3K Pathway in Pancreatic Ductal Adenocarcinoma: Rationale and Progress
por: Mehra, Siddharth, et al.
Publicado: (2021)

Emerging Role of CREB in Epithelial to Mesenchymal Plasticity of Pancreatic Cancer
por: Mehra, Siddharth, et al.
Publicado: (2022)

Minnelide effectively eliminates CD133(+) side population in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2015)

Resident stroma-secreted chemokine CCL2 governs myeloid-derived suppressor cells in the tumor microenvironment
por: Oo, May Wathone, et al.
Publicado: (2022)

Ras-p53 genomic cooperativity as a model to investigate mechanisms of innate immune regulation in gastrointestinal cancers
por: Dosch, Austin R., et al.
Publicado: (2021)

Viral vector-mediated reprogramming of the fibroblastic tumor stroma sustains curative melanoma treatment
por: Ring, Sandra S., et al.
Publicado: (2021)

Reprogramming the tumor microenvironment with biotechnology
por: Kim, Minjeong, et al.
Publicado: (2023)

Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy
por: Apollonio, Benedetta, et al.
Publicado: (2021)

The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment
por: Ni, Yanghong, et al.
Publicado: (2021)

Metabolic reprogramming of the ovarian cancer microenvironment in the development of antiangiogenic resistance: Metabolic reprogramming of the OC microenvironment
por: Yue, Huiran, et al.
Publicado: (2023)

CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2015)

Correction: Mishra, et al.; Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment. Cancers 2019, 11, 750
por: Mishra, Deepshikha, et al.
Publicado: (2020)

Inhibition of NF-kappa B pathway leads to deregulation of epithelial-mesenchymal transition and neural invasion in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2016)

E-Cadherin: An Enigma in Pancreatic Diseases
por: Garrido, Vanessa T., et al.
Publicado: (2019)

Characterization of the Tumor Microenvironment and Tumor–Stroma Interaction by Non-invasive Preclinical Imaging
por: Ramamonjisoa, Nirilanto, et al.
Publicado: (2017)

Breast Cancer Cell Invasion into a Three Dimensional Tumor-Stroma Microenvironment
por: Truong, Danh, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_he2so487kqvbm8h5utho25javn